Skip to main content
SpringerLink
Log in

Inflammatory bowel diseases and management considerations: Fertility and pregnancy

  • Published:
Current Gastroenterology Reports Aims and scope Submit manuscript

Abstract

Young women with inflammatory bowel disease (IBD) pose a unique set of challenges. These women and their treating physicians must make difficult choices in matters regarding conception, pregnancy, and breastfeeding. This review highlights recent evidence and management issues that arise when taking care of women with IBD in terms of fertility, outcomes, and medication safety in pregnancy and breastfeeding. Ultimately, treatment must be individualized for each patient based on the available evidence and the woman’s preferences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Munkholm P: Crohn’s disease—occurrence, course and prognosis. An epidemiologic cohort-study. Dan Med Bull 1997, 44:287–302.

    PubMed  CAS  Google Scholar 

  2. Andres PG, Friedman LS: Epidemiology and the natural course of inflammatory bowel disease. Gastroenterol Clin North Am 1999, 28:255–281, vii.

    Article  PubMed  CAS  Google Scholar 

  3. Baird DD, Narendranathan M, Sandler RS: Increased risk of preterm birth for women with inflammatory bowel disease. Gastroenterology 1990, 99:987–994.

    PubMed  CAS  Google Scholar 

  4. Hudson M, Flett G, Sinclair TS, et al.: Fertility and pregnancy in inflammatory bowel disease. Int J Gynaecol Obstet 1997, 58:229–237.

    Article  PubMed  CAS  Google Scholar 

  5. Waljee A, Waljee J, Morris AM, et al.: Threefold increased risk of infertility: a meta-analysis of infertility after ileal pouch anal anastomosis in ulcerative colitis. Gut 2006, 55:1575–1580.

    Article  PubMed  CAS  Google Scholar 

  6. Wikland M, Jansson I, Asztely M, et al.: Gynaecological problems related to anatomical changes after conventional proctocolectomy and ileostomy. Int J Colorectal Dis 1990, 5:49–52.

    Article  PubMed  CAS  Google Scholar 

  7. Olsen KO, Juul S, Bulow S, et al.: Female fecundity before and after operation for familial adenomatous polyposis. Br J Surg 2003, 90:227–231.

    Article  PubMed  CAS  Google Scholar 

  8. Mortier PE, Gambiez L, Karoui M: Colectomy with ileorectal anastomosis preserves female fertility in ulcerative colitis. Gastroenterol Clin Biol 2006, 30:594–597.

    PubMed  Google Scholar 

  9. Narendranathan M, Sandler RS, Suchindran CM, et al.: Male infertility in inflammatory bowel disease. J Clin Gastroenterol 1989, 11:403–406.

    Article  PubMed  CAS  Google Scholar 

  10. Levi AJ, Fisher AM, Hughes L, et al.: Male infertility due to sulphasalazine. Lancet 1979, 2:276–278.

    Article  PubMed  CAS  Google Scholar 

  11. Birnie GG, McLeod TI, Watkinson G: Incidence of sulphasalazine-induced male infertility. Gut 1981, 22:452–455.

    Article  PubMed  CAS  Google Scholar 

  12. Taffet SL, Das KM: Sulfasalazine. Adverse effects and desensitization. Dig Dis Sci 1983, 28:833–842.

    Article  PubMed  CAS  Google Scholar 

  13. Kjaergaard N, Christensen LA, Lauritsen JG, et al.: Effects of mesalazine substitution on salicylazosulfapyridineinduced seminal abnormalities in men with ulcerative colitis. Scand J Gastroenterol 1989, 24:891–896.

    Article  PubMed  CAS  Google Scholar 

  14. O’Morain C, Smethurst P, Dore CJ, et al.: Reversible male infertility due to sulphasalazine: studies in man and rat. Gut 1984, 25:1078–1084.

    Article  PubMed  Google Scholar 

  15. Riley SA, Lecarpentier J, Mani V, et al.: Sulphasalazine induced seminal abnormalities in ulcerative colitis: results of mesalazine substitution. Gut 1987, 28:1008–1012.

    Article  PubMed  CAS  Google Scholar 

  16. Chatzinoff M, Guarino JM, Corson SL, et al.: Sulfasalazine-induced abnormal sperm penetration assay reversed on changing to 5-aminosalicylic acid enemas. Dig Dis Sci 1988, 33:108–110.

    Article  PubMed  CAS  Google Scholar 

  17. DiPaolo MC, Paoluzi OA, Pica R, et al.: Sulphasalazine and 5-aminosalicylic acid in long-term treatment of ulcerative colitis: report on tolerance and side-effects. Dig Liver Dis 2001, 33:563–569.

    Article  CAS  Google Scholar 

  18. Saxena AK, Dhungel S, Bhattacharya S, et al.: Effect of chronic low dose of methotrexate on cellular proliferation during spermatogenesis in rats. Arch Androl 2004, 50:33–35.

    Article  PubMed  CAS  Google Scholar 

  19. Shrestha S, Dhungel S, Saxena AK, et al.: Effect of methotrexate (MTX) administration on spermatogenesis: an experimental on animal model. Nepal Med Coll J 2007, 9:230–233.

    PubMed  CAS  Google Scholar 

  20. Karbach U, Ewe K, Shramm P: Quality of semen in patients with Crohn’s disease. Z Gastroenterol 1982, 20:314–320.

    PubMed  CAS  Google Scholar 

  21. Hull MG, North K, Taylor H, et al.: Delayed conception and active and passive smoking. The Avon Longitudinal Study of Pregnancy and Childhood Study Team. Fertil Steril 2000, 74:725–733.

    Article  PubMed  CAS  Google Scholar 

  22. Laurent SL, Thompson SJ, Addy C, et al.: An epidemiologic study of smoking and primary infertility in women. Fertil Steril 1992, 57:565–572.

    PubMed  CAS  Google Scholar 

  23. Kalyani R, Basavaraj PB, Kumar ML: Factors influencing quality of semen: a two year prospective study. Indian J Pathol Microbiol 2007, 50:890–895.

    PubMed  CAS  Google Scholar 

  24. Emanuele MA, Emanuele NV: Alcohol’s effects on male reproduction. Alcohol Health Res World 1998, 22:195–201.

    PubMed  CAS  Google Scholar 

  25. El-Tawil AM: Zinc deficiency in men with Crohn’s disease may contribute to poor sperm function and male infertility. Andrologia 2003, 35:337–341.

    Article  PubMed  CAS  Google Scholar 

  26. Morales M, Berney T, Jenny A, et al.: Crohn’s disease as a risk factor for the outcome of pregnancy. Hepatogastroenterology 2000, 47:1595–1598.

    PubMed  CAS  Google Scholar 

  27. Nielsen OH, Andreasson B, Bondesen S, et al.: Pregnancy in ulcerative colitis. Scand J Gastroenterol 1983, 18:735–742.

    Article  PubMed  CAS  Google Scholar 

  28. Bush MC, Patel S, Lapinski RH, et al.: Perinatal outcomes in inflammatory bowel disease. J Matern Fetal Neonatal Med 2004, 15:237–241.

    Article  PubMed  CAS  Google Scholar 

  29. Fedorkow DM, Persaud D, Nimrod CA: Inflammatory bowel disease: a controlled study of late pregnancy outcome. Am J Obstet Gynecol 1989, 160:998–1001.

    PubMed  CAS  Google Scholar 

  30. Cornish J, Tan E, Teare J: A meta-analysis on the influence of inflammatory bowel disease on pregnancy Gut 2007, 56:830–837.

    Article  PubMed  CAS  Google Scholar 

  31. Mahadevan U, Sandborn WJ, Li DK, et al.: Pregnancy outcomes in women with inflammatory bowel disease: a large community-based study from Northern California. Gastroenterology 2007, 133:1106–1112.

    Article  PubMed  Google Scholar 

  32. Norgärd B, Pedersen L, Christensen LA, Sørensen HT: Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study Am J Gastroenterol 2007, 102:1406–1413.

    Article  PubMed  CAS  Google Scholar 

  33. Nguyen GC, Boudreau H, Harris ML, Maxwell CV: Outcomes of obstetric hospitalizations among women with inflammatory bowel disease in the United States Clin Gastroenterol Hepatol 2009, 7:329–334.

    Article  PubMed  Google Scholar 

  34. Riis L, Vind I, Politi P: Does pregnancy change the disease course? A study in a European cohort of patients with inflammatory bowel disease. Am J Gastroenterol 2006, 101:1539–1545.

    Article  PubMed  Google Scholar 

  35. Reddy D, Murphy SJ, Kane SV: Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Am J Gastroenterol 2008, 103:1203–1209.

    Article  PubMed  CAS  Google Scholar 

  36. Mogadam M, Korelitz BI, Ahmed SW, et al.: The course of inflammatory bowel disease during pregnancy and postpartum. Am J Gastroenterol 1981, 75:265–269.

    PubMed  CAS  Google Scholar 

  37. Beniada A, Benoist G, Maurel J, et al.: Inflammatory bowel disease and pregnancy: report of 76 cases and review of the literature. J Gynecol Obstet Biol Reprod (Paris) 2005, 34:581–588.

    CAS  Google Scholar 

  38. Kane S, Lemieux N: The role of breastfeeding in postpartum disease activity in women with inflammatory bowel disease. Am J Gastroenterol 2005, 100:102–105.

    Article  PubMed  Google Scholar 

  39. US Food and Drug Administration: Food and Drug Administration categories for the use of medications in pregnancy. Regulations 1980:37434–37467.

  40. Craxi A, Pagliarello F: Possible embryotoxicity of sulfasalazine. Arch Intern Med 1980, 140:1674.

    Article  PubMed  CAS  Google Scholar 

  41. Hoo JJ, Hadro TA, Von Behren P: Possible teratogenicity of sulfasalazine. N Engl J Med 1988, 318:1128.

    PubMed  CAS  Google Scholar 

  42. Newman NM, Correy JF: Possible teratogenicity of sulphasalazine. Med J Aust 1983, 1:528–529.

    PubMed  CAS  Google Scholar 

  43. Mogadam M, Dobbins WO 3rd, Korelitz BI, et al.: Pregnancy in inflammatory bowel disease: effect of sulfasalazine and corticosteroids on fetal outcome. Gastroenterology 1981, 80:72–76.

    PubMed  CAS  Google Scholar 

  44. Norgård B, Czeizel AE, Rockenbauer M, et al.: Population-based case control study of the safety of sulfasalazine use during pregnancy. Aliment Pharmacol Ther 2001, 15:483–486.

    Article  PubMed  Google Scholar 

  45. Rahimi R, Nikfar S, Rezaie A, Abdollahi M: Pregnancy outcome in women with inflammatory bowel disease following exposure to 5-aminosalicylic acid drugs: a metaanalysis. Reprod Toxicol 2008, 25:271–275.

    Article  PubMed  CAS  Google Scholar 

  46. Park-Wyllie L, Mazzotta P, Pastuszak A, et al.: Birth defects after maternal exposure to corticosteroids: prospective cohort study and meta-analysis of epidemiological studies. Teratology 2000, 62:385–392.

    Article  PubMed  CAS  Google Scholar 

  47. Beaulieu DB, Ananthakrishnan AN, Issa M: Budesonide induction and maintenance therapy for Crohn’s disease during pregnancy. Inflamm Bowel Dis 2009, 15:25–28.

    Article  PubMed  Google Scholar 

  48. Polifka JE, Friedman JM: Teratogen update: azathioprine and 6-mercaptopurine. Teratology 2002, 65:240–261.

    Article  PubMed  CAS  Google Scholar 

  49. Norgård B, Pedersen L, Christensen LA, et al.: Therapeutic drug use in women with Crohn’s disease and birth outcomes: a Danish nationwide cohort study. Am J Gastroenterol 2007, 102:1406–1413.

    Article  PubMed  CAS  Google Scholar 

  50. Christensen LA, Dahlerup JF, Nielsen MJ: Azathioprine treatment during lactation. Aliment Pharmacol Ther 2008, 28:1209–1213.

    Article  PubMed  CAS  Google Scholar 

  51. Kane SV, Acquah LA: Placental transport of immunoglobulins: a clinical review for gastroenterologists who prescribe therapeutic monoclonal antibodies to women during conception and pregnancy. Am J Gastroenterol 2009, 104:228–233.

    Article  PubMed  CAS  Google Scholar 

  52. Lichtenstein GR, Feagan BG, Cohen RD, et al.: Serious infections and mortality in association with therapies for Crohn’s disease: TREAT registry. Clin Gastroenterol Hepatol 2006, 4:621–630.

    Article  PubMed  CAS  Google Scholar 

  53. Katz JA, Antoni C, Keenan GF, et al.: Outcome of pregnancy in women receiving infliximab for the treatment of Crohn’s disease and rheumatoid arthritis. Am J Gastroenterol 2004, 99:2385–2392.

    Article  PubMed  Google Scholar 

  54. Kane S, Ford J, Cohen R, Wagner C: Absence of infliximab in infants and breast milk from nursing mothers receiving therapy for Crohn’s disease before and after delivery. J Clin Gastroenterol 2009, 43:613–616.

    Article  PubMed  CAS  Google Scholar 

  55. Coburn LA, Wise PE, Schwartz DA: The successful use of adalimumab to treat active Crohn’s disease of an ileoanal pouch during pregnancy. Dig Dis Sci 2006, 51:2045–2047.

    Article  PubMed  Google Scholar 

  56. Mishkin DS, Van Deinse W, Becker JM, et al.: Successful use of adalimumab (Humira) for Crohn’s disease in pregnancy. Inflamm Bowel Dis 2006, 12:827–828.

    Article  PubMed  Google Scholar 

  57. Vesga L, Terdiman JP, Mahadevan U: Adalimumab use in pregnancy. Gut 2005, 54:890.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine, 200 First Street SW, Rochester, MN, 55905, USA

    Sunanda Kane

Authors
  1. Maria Moscandrew
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sunanda Kane
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Sunanda Kane.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moscandrew, M., Kane, S. Inflammatory bowel diseases and management considerations: Fertility and pregnancy. Curr Gastroenterol Rep 11, 395–399 (2009). https://doi.org/10.1007/s11894-009-0059-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11894-009-0059-6

Keywords

Search

Navigation